Exploitation of herpesviral transactivation allows quantitative reporter gene-based assessment of virus entry and neutralization

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Reinhard, Henrike ^a,c   Le, Vu Thuy Khanh ^a   Ohlin, Mats ^b   Hengel, Hartmut ^a   Trilling, Mirko ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTISERUM; BETA INTERFERON; IMMUNOGLOBULIN; INTERFERON REGULATORY FACTOR 3; LUCIFERASE; MONOCLONAL ANTIBODY; PP72 IE1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS ANTIBODY;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ENHANCER REGION; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HUMAN; HUMAN CELL; INTERFERON INDUCTION; NONHUMAN; PROMOTER REGION; REPORTER GENE; TRANSACTIVATION; ULTRAVIOLET IRRADIATION; VIRION; VIRUS ENTRY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; ANIMAL; ANTIGEN ANTIBODY REACTION; GENETICS; IMMUNOLOGY; MOUSE; MUROMEGALOVIRUS; PHYSIOLOGY; SERODIAGNOSIS; TRANSCRIPTION INITIATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 5;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN-ANTIBODY REACTIONS; CYTOMEGALOVIRUS; GENES, REPORTER; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MUROMEGALOVIRUS; NEUTRALIZATION TESTS; TRANSCRIPTIONAL ACTIVATION; VIRUS INTERNALIZATION;

EID: 79251576807     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014532     Document Type: Article

References (51)

1. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5: 47.
2. Stagno S, Pass RF, Cloud G, Britt WJ, Henderson RE, et al. (1986) Primary Cytomegalovirus-Infection in Pregnancy - Incidence, Transmission to Fetus, and Clinical Outcome. Jama-Journal of the American Medical Association 256: 1904-1908.
3. Boppana SB, Smith RJ, Stagno S, Britt WJ (1992) Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection. J Clin Microbiol 30: 721-723.
4. Mussi-Pinhata MM, Yamamoto AY, Brito RMM, Isaac MD, Oliveira PFDE, et al. (2009) Birth Prevalence and Natural History of Congenital Cytomegalovirus Infection in a Highly Seroimmune Population. Clinical Infectious Diseases 49: 522-528.
5. Fowler KB, Boppana SB (2006) Congenital cytomegalovirus (CMV) infection and hearing deficit. J Clin Virol 35: 226-231.
6. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, et al. (1992) The Outcome of Congenital Cytomegalovirus-Infection in Relation to Maternal Antibody Status. New England Journal of Medicine 326: 663-667.
7. Fowler KB, Stagno S, Pass RF (2003) Maternal immunity and prevention of congenital cytomegalovirus infection. Jama-Journal of the American Medical Association 289: 1008-1011.
8. Stagno S, Pass RF, Dworsky ME, Henderson RE, Moore EG, et al. (1982) Congenital Cytomegalovirus-Infection - the Relative Importance of Primary and Recurrent Maternal Infection. New England Journal of Medicine 306: 945-949.
9. Jonjic S, Pavic I, Polic B, Crnkovic I, Lucin P, et al. (1994) Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J Exp Med 179: 1713-1717.
10. Burton DR (2002) Antibodies, viruses and vaccines. Nature Reviews Immunology 2: 706-713.
11. Nigro G, Adler SP, La TR, Best AM (2005) Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 353: 1350-1362.
12. Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6: 231-243.
13. Eggers M, Metzger C, Enders G (1998) Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay. J Med Virol 56: 351-358.
14. Eggers M, Radsak K, Enders G, Reschke M (2001) Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy. J Med Virol 63: 135-142.
15. Gerna G, Sarasini A, Patrone M, Percivalle E, Fiorina L, et al. (2008) Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 89: 853-865.
16. Wang D, Shenk T (2005) Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci U S A 102: 18153-18158.
17. Abai AM, Smith LR, Wloch MK (2007) Novel microneutralization assay for HCMV using automated data collection and analysis. J Immunol Methods 322: 82-93.
18. Andreoni M, Faircloth M, Vugler L, Britt WJ (1989) A rapid microneutralization assay for the measurement of neutralizing antibody reactive with human cytomegalovirus. J Virol Methods 23: 157-167.
19. Frank I, Friedman HM (1989) A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J Virol 63: 4479-4488.
20. Campadelli-Fiume G, Amasio M, Avitabile E, Cerretani A, Forghieri C, et al. (2007) The multipartite system that mediates entry of herpes simplex virus into the cell. Rev Med Virol 17: 313-326.
21. Wang D, Yu QC, Schroer J, Murphy E, Shenk T (2007) Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells. Proc Natl Acad Sci U S A 104: 20037-20042.
22. Hengel H, Koszinowski UH, Conzelmann KK (2005) Viruses know it all: new insights into IFN networks. Trends Immunol 26: 396-401.
23. Marshall EE, Geballe AP (2009) Multifaceted evasion of the interferon response by cytomegalovirus. J Interferon Cytokine Res 29: 609-619.
24. Jerome KR, Fox R, Chen Z, Sears AE, Lee H, et al. (1999) Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J Virol 73: 8950-8957.
25. Rodriguez JE, Loepfe TR, Swack NS (1987) Beta interferon production in primed and unprimed cells infected with human cytomegalovirus. Arch Virol 94: 177-189.
26. Diaz MO, Ziemin S, Le Beau MM, Pitha P, Smith SD, et al. (1988) Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A 85: 5259-5263.
27. Ohe Y, Zhao D, Saijo N, Podack ER (1995) Construction of a novel bovine papillomavirus vector without detectable transforming activity suitable for gene transfer. Hum Gene Ther 6: 325-333.
28. Honess RW, Roizman B (1975) Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A 72: 1276-1280.
29. Leiden JM, Buttyan R, Spear PG (1976) Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus. J Virol 20: 413-424.
30. Lin SS, Munyon W (1974) Expression of the viral thymidine kinase gene in herpes simplex virus-transformed L cells. J Virol 14: 1199-1208.
31. Burkhardt C, Himmelein S, Britt W, Winkler T, Mach M (2009) Glycoprotein N subtypes of human cytomegalovirus induce a strain-specific antibody response during natural infection. J Gen Virol 90: 1951-1961.
32. Ohlin M, Sundqvist VA, Mach M, Wahren B, Borrebaeck CA (1993) Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol 67: 703-710.
33. Pereira L, Klassen T, Baringer JR (1980) Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun 29: 724-732.
34. Krummenacher C, Baribaud I, de Leon MP, Whitbeck JC, Lou H, et al. (2000) Localization of a binding site for herpes simplex virus glycoprotein D on herpesvirus entry mediator C by using antireceptor monoclonal antibodies. Journal of Virology 74: 10863-10872.
35. Lopez M, Cocchi F, Menotti L, Avitabile E, Dubreuil P, et al. (2000) Nectin2 alpha (PRR2 alpha or HveB) and nectin2 delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. Journal of Virology 74: 1267-1274.
36. Nicola AV, de Leon MP, Xu RL, Hou WF, Whitbeck JC, et al. (1998) Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. Journal of Virology 72: 3595-3601.
37. Hahn G, Revello MG, Patrone M, Percivalle E, Campanini G, et al. (2004) Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 78: 10023-10033.
38. Antonsson A, Johansson PJ (2001) Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus. J Gen Virol 82: 1137-1145.
39. Atalay R, Zimmermann A, Wagner M, Borst E, Benz C, et al. (2002) Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. J Virol 76: 8596-8608.
40. Lilley BN, Ploegh HL, Tirabassi RS (2001) Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J Virol 75: 11218-11221.
41. Sprague ER, Reinhard H, Cheung EJ, Farley AH, Trujillo RD, et al. (2008) The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. J Virol 82: 3490-3499.
42. Baucke RB, Spear PG (1979) Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol 32: 779-789.
43. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND (1988) Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 62: 1347-1354.
44. Pahl HL, Baeuerle PA (1995) Expression of influenza virus hemagglutinin activates transcription factor NF-kappa B. J Virol 69: 1480-1484.
45. Hengel H, Esslinger C, Pool J, Goulmy E, Koszinowski UH (1995) Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 76(Pt 12): 2987-2997.
46. Borst EM, Hahn G, Koszinowski UH, Messerle M (1999) Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J Virol 73: 8320-8329.
47. Sinzger C, Hahn G, Digel M, Katona R, Sampaio KL, et al. (2008) Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol 89: 359-368.
48. Wang X, Messerle M, Sapinoro R, Santos K, Hocknell PK, et al. (2003) Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J Virol 77: 7182-7192.
49. Stinski MF (1976) Human cytomegalovirus: glycoproteins associated with virions and dense bodies. J Virol 19: 594-609.
50. Le VT, Trilling M, Wilborn M, Hengel H, Zimmermann A (2008) Human cytomegalovirus interferes with signal transducer and activator of transcription (STAT) 2 protein stability and tyrosine phosphorylation. J Gen Virol 89: 2416-2426.
51. Le VT, Trilling M, Zimmermann A, Hengel H (2008) Mouse cytomegalovirus inhibits beta interferon (IFN-beta) gene expression and controls activation pathways of the IFN-beta enhanceosome. J Gen Virol 89: 1131-1141.